MLchartDataset catalogue

IL-13

Term · Oncology and biomedicine · MLC-T-ONC-004155

One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-13 is made by a type of T lymphocyte. It reduces inflammation by blocking production of cytokines by macrophages. It also increases the number and activity of B lymphocytes. IL-13 made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. It is a type of cytokine. Also called interleukin-13.

Table 1. Record
IdentifierMLC-T-ONC-004155
FieldOncology and biomedicine
Expansionsinterleukin-13
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004155",
  "term": "IL-13",
  "field": "Oncology and biomedicine",
  "definition": "One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-13 is made by a type of T lymphocyte. It reduces inflammation by blocking production of cytokines by macrophages. It also increases the number and activity of B lymphocytes. IL-13 made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. It is a type of cytokine. Also called interleukin-13.",
  "expansions": [
    "interleukin-13"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/il-13/"
}

Record 8,995 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.